Specific packaging of DNA affects cell division
LMU molecular biologists were able to show that, contrary to prevalent assumptions, this unique packaging is not just an obstacle, but a crucial element for replication.
“It is one of the very fundamental processes of life, and gaining a deeper understanding of it is important in its own right. In addition, both replication and the chromatin structure go awry in the case of cancer cells, for example. That we’ve been able to bring these two aspects together could help with the development of better drugs in the future.“
Dr. Christoph F. Kurat, Principal Investigator at LMU’s Biomedical Center (BMC)
The DNA molecule is located in the cell nucleus as a densely packed complex of DNA and protein, known as chromatin. Wrapped in sections around a core of special proteins known as histones, the DNA forms so-called nucleosomes, which are organized along the DNA like pearls on a string. For one of the fundamental processes of life, replication, the doubling of DNA, the standard textbook view tended to see this literally tangled structure as a hindrance that had to be loosened up and overcome with the expenditure of energy. A team led by molecular biologist Dr. Christoph F. Kurat from LMU’s Biomedical Center (BMC) has now shown that this is not the whole truth: At certain places in the genome, the starting points of replication, a characteristic nucleosome structure is crucial for replication to get going in the first place, as the researchers report in the journal Nature.
Before a cell can divide, its DNA has to double. This process does not initiate at one place only, rather the molecular machines of replication get to work simultaneously at many starting points along the chromosomes. Human cells possess around 30,000 of these so-called replication origins, while the single-celled baker’s yeast with a small genome, which Kurat’s team investigated as a model organism, possesses around 400 of them. Some time ago, researchers had discovered characteristic chromatin structures at these origins: The nucleosomes at these sites are arranged in very regular fashion, “in a much more orderly way than in the rest of the genome,” says Kurat.
Minimalist models in test tubes
To investigate how this structural regularity comes about and how it affects replication, Kurat and his team worked for years to isolate the proteins and origins involved in the replication of yeast cells, so that they could reproduce a functional replication system in test tubes. “Such a biochemical reconstitution approach is extremely laborious,” emphasizes Kurat, “but also highly valuable for understanding complicated processes in detail. So it was a boon for us that we had such fruitful collaboration with colleagues at the BMC and at the Max Planck Institute for Biochemistry.”
With these reconstitutions, the researchers were able to demonstrate which factors generate the regular chromatin structure at the origins and how important this is for the replication machinery to get going at their starting points. “Mutated cells without this chromatin structure are not viable,” says Erika Chacin, lead author of the study. A key factor for the start of replication is the protein complex ORC (Origin Recognition Complex), of which it has long been known that it recruits the necessary parts of the replication machines. To their surprise, the researchers discovered that this complex has a second function: It plays a crucial role in the genesis of the highly ordered chromatin structure at the origins, by arranging the nucleosomes accordingly in conjunction with so-called chromatin remodeler complexes.
“Our results give scientists a better understanding of replication,” says Kurat. “It is one of the very fundamental processes of life, and gaining a deeper understanding of it is important in its own right. In addition, both replication and the chromatin structure go awry in the case of cancer cells, for example. That we’ve been able to bring these two aspects together could help with the development of better drugs in the future. Many cancer drugs inhibit DNA replication, which is associated with strong side effects. The chromatin structure could be a new lever we could employ going forward.”
The paper is available here: www.nature.com/articles/s41586-023-05926-8
- Marchioninistraße 15
- 81377 München
- Phone: +49 (0)89/4400 – 72101